Cardiology

The updated transcatheter aortic valve replacement system incorporates a supra-annular valve design, with a redesigned catheter tip and 4 valve sizes.

Announced on August 24, rivaroxaban (Xarelto) has received its ninth indication from the US FDA. This time, the FDA has approved a label expansion to include patients with symptomatic peripheral artery disease who have undergone lower extremity revascularization.

With approval of the Evolut FX TAVR System announced on August 24, the Evolut TAVR Platform is now indicated for symptomatic severe aortic stenosis across all patient risk categories.

The newest indication for the anticoagulant is based on phase 3 VOYAGER PAD findings showing benefit in reduced risk of major cardiovascular events among post-revascularization patients with PAD.

Dr. Gregory Weiss tackles the topic of physician burnout in cardiology and offers perspective on the most common causes as well as possible methods of intervention to mitigate the impact of burnout.

New data suggests patients with a history of diabetes, hypertension, or cardiovascular disease were at increased risk of worsening hypoxemia compared to their counterparts without these conditions.

A new meta-analysis by investigators from Johns Hopkins details the prevalence of UACR testing in patient populations at increased risk of albuminuria, suggesting less than 40% of patients with diabetes underwent UACR testing and this figure dropped to less than 5% among patients with hypertension.

Pictorial data on carotid intima-media thickness and presence of carotid plaques can improve prescription of lipid-lowering drugs.

Data from a cross-sectional analysis details contemporary trends in industry payments and authorship of commentaries related to recent RCTs examining cardiovascular interventions.

A new study leveraging data from the PINNACLE registry provides an overview of racial, socioeconomic, geographic, and practice-level factors that play a role in odds of receiving a prescription for a PCSK9 inhibitor among patients with ASCVD and suboptimal LDL-C.

All NOACs had a lower risk of stroke or SE compared to warfarin, including apixaban, dabigatran, and rivaroxaban.

Patients with severe mental health issues often are linked to health inequalities that contribute to a shorter life expectancy than the general population.

Data show 15% of authors in this analysis reported financial associations with trial sponsors in invasive cardiovascular intervention studies.

Most common factor for hospitalizations of T2D include cardiac disorder, infections and infestations, and nervous system disorders.

The mapping system incorporate referencing based on 3D navigation, similar to what is used for brain, spine, ENT, and lung surgeries.

The latest scientific statement from the American Heart Association seeks to outline the cardiovascular risks associated with OSA or sleep-disordered breathing in children and adolescents while also providing insight into symptoms and risk factors for developing OSA or sleep-disordered breathing.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

The main mechanism for exercise intolerance is impaired blood oxygen carrying capacity.

The study notes the importance of follow-up monitoring of sleep apnea in patients with IH.

There was little difference in hospitalization and mortality rates between vaccinated schizophrenia patients and vaccinated control patients.

An analysis of data from a prospective cohort study of more than 50k suggests increased intake of vitamin K could lower a person's risk of ASCVD hospitalization by more than 20%.

The technology will be implemented into Acutus Medical’s AcQMap 3D imaging and mapping systems.

Investigators believe benefit of COVID-19 vaccination outweigh the risk of myocarditis in adolescent population.

In an analysis, low GI/GL dietary patterns resulted in a reduction in HbA1c, compared with control diets with a mean difference of −0.31.

Dr. Gregory Weiss reflects on the history of artificial intelligence in cardiology and offers perspective on its evolving role as artificial intelligence has demonstrated its ability to improve care and clinical decision-making.